MLN8054 selectively inhibits Aurora A over Aurora B in cultured human tumor cells.

被引：0
|
作者：
Hoar, KM [1 ]
Wysong, DR [1 ]
Ecsedy, JA [1 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9109S / 9109S
页数：1
相关论文
共 50 条
  • [1] Effect of aurora A inhibition in cultured human tumor cells using the selective small molecule inhibitor MLN8054
    Ecsedy, Jeffrey A.
    Hoar, Kara
    Wysong, Deborah R.
    Rabino, Claudia
    Bowman, Douglas S.
    Chakravarty, Arijit
    Roy, Natalie
    CANCER RESEARCH, 2006, 66 (08)
  • [2] MLN8054, an Inhibitor of Aurora A Kinase, Induces Senescence in Human Tumor Cells Both In vitro and In vivo
    Huck, Jessica J.
    Zhang, Mengkun
    McDonald, Alice
    Bowman, Doug
    Hoar, Kara M.
    Stringer, Bradley
    Ecsedy, Jeffery
    Manfredi, Mark G.
    Hyer, Marc L.
    MOLECULAR CANCER RESEARCH, 2010, 8 (03) : 373 - 384
  • [3] MLN8054, an inhibitor of Aurora A Kinase, induces senescence in human tumor cells both in vitro and in vivo.
    Hyer, Marc
    Huck, Jessica
    Chakravarty, Arijit
    Bowman, Doug
    Zhang, Menkun
    Ecsedy, Jeff
    McDonald, Alice
    Stringer, Bradley
    Manfredi, Mark
    CANCER RESEARCH, 2009, 69
  • [4] MLN8054, an Aurora A kinase inhibitor, inhibits proliferation of cultured human tumor cells by p53-dependent and p53-independent mechanisms.
    LeRoy, PJ
    Wysong, DR
    Hoar, KM
    Ecsedy, JA
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9108S - 9108S
  • [5] MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
    Sells, Todd B.
    Chau, Ryan
    Ecsedy, Jeffrey A.
    Gershman, Rachel E.
    Hoar, Kara
    Huck, Jessica
    Janowick, David A.
    Kadambi, Vivek J.
    LeRoy, Patrick J.
    Stirling, Matthew
    Stroud, Stephen G.
    Vos, Tricia J.
    Weatherhead, Gabriel S.
    Wysong, Deborah R.
    Zhang, Mengkun
    Balani, Suresh K.
    Bolen, Joseph B.
    Manfredi, Mark G.
    Claiborne, Christopher F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (06): : 630 - 634
  • [6] Phase I and pharmacokinetic study of MLN8054, a selective inhibitor of Aurora A kinase
    Dees, E.
    Infante, J. R.
    Cohen, R. B.
    O'Neil, B.
    Burris, H.
    von Mehren, M.
    Gray, G.
    Galvin, K.
    Manfredi, M.
    Eton, O.
    EJC SUPPLEMENTS, 2008, 6 (12): : 91 - 91
  • [7] Preclinical antitumor activity with MLN8054, a small molecule Aurora A kinase inhibitor
    Huck, Jessica
    Zhang, Mengkun
    Burenkova, Olga
    Connolly, Kelly
    Manfredi, Mark
    Meetze, Kristan
    CANCER RESEARCH, 2006, 66 (08)
  • [8] MLN8054, an Aurora A Kinase inhibitor, demonstrates potent anti-tumor activity in disseminated tumor models
    Zhang, M.
    Meetze, M.
    Huck, J.
    Silva, M.
    Sells, T.
    Claiborne, C.
    Manfredi, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 113 - 113
  • [9] Crystal structure of an Aurora-A mutant that mimics Aurora-B bound to MLN8054: insights into selectivity and drug design
    Dodson, Charlotte A.
    Kosmopoulou, Magda
    Richards, Mark W.
    Atrash, Butrus
    Bavetsias, Vassilios
    Blagg, Julian
    Bayliss, Richard
    BIOCHEMICAL JOURNAL, 2010, 427 : 19 - 28
  • [10] Phase I clinical trial of MLN8054, a selective inhibitor of Aurora A kinase
    Jones, S. F.
    Cohen, R. B.
    Dees, E. C.
    Lee, Y.
    Papas, J. A.
    Cooper, M. R.
    Galvin, K. M.
    Burris, H. A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345